←Back to Expert Scholars
Translational Medicine / 转化医学MET Exon 14 Skipping Alterations
Enriqueta Felip
MD, PhD
🏢Vall d'Hebron Institute of Oncology🌐Spain
Head, Thoracic Oncology Unit
68
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Enriqueta Felip leads thoracic oncology at Vall d'Hebron and is a key European investigator in MET-targeted therapy trials. She has contributed to understanding the interplay between MET alterations and immunotherapy response. Her work spans multiple pivotal MET inhibitor registrational studies.
Share:
🧪Research Fields 研究领域
MET exon 14 skipping
Targeted therapy
NSCLC biomarkers
European oncology trials
Immunotherapy combinations
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Enriqueta Felip 的研究动态
Follow Enriqueta Felip's research updates
留下邮箱，当我们发布与 Enriqueta Felip（Vall d'Hebron Institute of Oncology）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment